[144] BITMINE IMMERSION TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

BitMine Immersion Technologies, Inc. (BMNR) Form 144 notifies the SEC of a proposed sale of 100,000 common shares to be executed through UBS Securities LLC on 09/22/2025 with an aggregate market value of $5,510,000.00. The filing shows the shares were acquired on 08/26/2025 as a partnership distribution from Innovative Digital Investors Emerging Technology LP and records 252,044 shares received in that distribution. The notice also reports a prior sale by the same account of 250,000 shares on 09/11/2025 generating gross proceeds of $10,136,778.00. The filer attests they are not aware of undisclosed material adverse information.

Positive

• Regulatory compliance: The filing discloses the proposed sale under Rule 144 and names the executing broker (UBS Securities LLC), enhancing transparency.
• Detailed transaction records: Includes acquisition date (08/26/2025), nature of acquisition (partnership distribution), and recent sale proceeds ($10,136,778.00), which aid investor assessment.

Negative

• Large insider-related sales: Proposed sale of 100,000 shares and a recent sale of 250,000 shares could increase free float and pressure the share price short-term.
• Ambiguity on filer status: The form does not explicitly state whether the seller is an affiliate or officer, which limits interpretation of governance and insider intent.

Insights

Securities Analyst

TL;DR: Large insider-related share sales disclosed; material size but appears procedural compliance rather than a corporate disclosure event.

The Form 144 documents a meaningful quantity of common stock being distributed and slated for sale within a short window: 252,044 shares acquired by partnership distribution and a proposed 100,000-share sale valued at $5.51M, plus a recent 250,000-share sale that yielded ~$10.14M. For investors this is notable because concentrated insider sales can increase free float and affect short-term supply. The filing itself complies with Rule 144 disclosure requirements and names the executing broker (UBS), which aids transparency. No earnings, corporate actions, or undisclosed material facts are contained in this form.

Corporate Governance Expert

TL;DR: Disclosure indicates compliance with trading rules but raises governance questions about timing and dilution.

The report shows securities acquired by distribution from a limited partnership and subsequent dispositions within weeks. While Form 144 is a routine disclosure mechanism, clustered transfers and sales by persons included under Rule 144 definitions warrant attention to whether the sales follow documented trading plans and insider trading policies. The filer’s attestation that no undisclosed material adverse information exists is standard; however, the form does not provide the filers status (e.g., officer, director, affiliate), leaving ambiguity about insider governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 11 Madison Avenue New York NY 10010	100000	5510000.00	279524602	09/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2025	Partnership Distribution	Innovative Digital Investors Emerging Technology LP			252044	08/26/2025	Partnership Distribution

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bates Jonathan Robert 10845 GRIFFITH PEAK DR. #2 LAS VEGAS NV 89135	Common Stock	09/11/2025	250000	10136778.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BMNR Form 144 disclose?

It discloses a proposed sale of 100,000 common shares via UBS Securities LLC on 09/22/2025 with an aggregate market value of $5,510,000.00.

When and how were the shares being sold on BMNR acquired?

The filing shows the shares were acquired on 08/26/2025 as a partnership distribution from Innovative Digital Investors Emerging Technology LP, totaling 252,044 shares received.

Has the filer sold BMNR shares recently?

Yes. The filing reports a sale on 09/11/2025 of 250,000 shares for gross proceeds of $10,136,778.00.

Who is the broker handling the proposed BMNR sale?

The executing broker named in the Form 144 is UBS Securities LLC, located at 11 Madison Avenue, New York, NY 10010.

Does the filer state there is undisclosed material information about BMNR?

The filer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.